| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Abcellera Biologics Inc. (ABCL) has 8 insiders with recent SEC Form 4 filings, including 9 buys and 3 sells. ABCL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 56.13M | $310.42M | - | |
| CEO | 13.10M | $72.43M | - | |
| CFO | 8.75M | $48.40M | - | |
| Other | 5.20M | $28.76M | - | |
| Other | 4.65M | $25.69M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 12, 2022 | Thermopylae Holdings Ltd.63 | 10% Owner | Buy | 1,408,468 | $6.41 | $9,021,800.93 | +2.6% | +98.8% | -14.5% | |
| Mar 4, 2022 | Montalbano John S.52 | Director | Buy | 10,000 | $8.54 | $85,400.00 | +21.7% | -9.5% | -1.8% | |
| Mar 1, 2022 | Montalbano John S.52 | Director | Buy | 20,000 | $9.05 | $181,000.00 | +76.9% | -15.7% | -9.8% | |
| Feb 28, 2022 | Lecault Veronique48 | Chief Operating Officer | Buy | 230,789 | $8.66 | $1,998,632.74 | +17.2% | -12.5% | -3.6% | |
| Dec 3, 2021 | Lo Andrew | Director | Buy | 86,938 | $14.02 | $1,218,870.76 | New | -35.5% | -9.3% | |
| Nov 11, 2021 | Booth Andrew | Chief Financial Officer | Buy | 67,500 | $14.71 | $993,130.00 | +57.7% | -35.7% | -9.8% | |
| Nov 11, 2021 | Thermopylae Holdings Ltd.63 | 10% Owner | Buy | 202,960 | $14.76 | $2,995,912.86 | +0.4% | -35.7% | -9.8% | |
| Sep 1, 2021 | Hamer John | Director | Sell | 300,000 | $16.94 | $5,082,252.98 | -43.2% | -11.6% | -34.6% | |
| Aug 16, 2021 | Montalbano John S.52 | Director | Buy | 6,000 | $17.23 | $103,380.00 | +30.0% | -7.2% | -27.8% | |
| Jun 22, 2021 | Hayden Michael R58 | Director | Sell | 100,000 | $25.50 | $2,550,000.00 | -9.1% | -6.4% | -53.4% |